Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of LAS41008 vs LASW1835 vs placebo in moderate to severe plaque psoriasis
2012-000055-13Phase 3Completed
- Sponsor
- Almirall
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dimethyl fumarate in plaque psoriasis and psoriasis (3 arms), sponsored by Almirall. Primary endpoint: Primary efficacy variables. Started Aug 2012; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on 2012-000055-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000055-13.